PRESS RELEASE published on 12/29/2025 at 08:00, 5 months 25 days ago Informations privilégiées / Autres communiqués GenSight Biologics réalise une levée de fonds de près de €2,9 millions d’euros pour développer des thérapies géniques innovantes. La société vise le traitement des maladies neurodégénératives de la rétine Levée De Fonds GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Rétine
PRESS RELEASE published on 12/29/2025 at 08:00, 5 months 25 days ago Inside Information / Other news releases GenSight Biologics successfully raises nearly €2.9 million to fund gene therapies for retinal neurodegenerative diseases, plans to use proceeds for development and operational needs through 2026 Fundraising Proceeds GenSight Biologics Gene Therapies Retinal Diseases
BRIEF published on 12/22/2025 at 07:05, 6 months 1 day ago Issuance of a compassionate access authorization for GS010/LUMEVOQ® Gene Therapy GenSight Biologics NOHL ANSM Compassionate Access
BRIEF published on 12/22/2025 at 07:05, 6 months 1 day ago GenSight Biologics Receives Compassionate Use Authorization for GS010/LUMEVOQ® in France Gene Therapy Rare Diseases Compassionate Use LHON Treatment ANSM Approval
BRIEF published on 12/22/2025 at 07:05, 6 months 1 day ago GenSight Biologics obtient une autorisation d'usage compassionnel pour GS010/LUMEVOQ® en France Thérapie Génique Maladies Rares Usage Compassionnel Traitement De La LHON Approbation ANSM
BRIEF published on 12/22/2025 at 07:05, 6 months 1 day ago Délivrance d'une autorisation d'accès compassionnel pour GS010/LUMEVOQ® Thérapie Génique GenSight Biologics NOHL Accès Compassionnel ANSM
PRESS RELEASE published on 12/22/2025 at 07:00, 6 months 1 day ago Inside Information / Other news releases GenSight Biologics receives Compassionate Use Authorization in France for GS010/LUMEVOQ® gene therapy indicated for ND4-LHON treatment France GenSight Biologics GS010/LUMEVOQ® Compassionate Use Authorization ND4-LHON
PRESS RELEASE published on 12/22/2025 at 07:00, 6 months 1 day ago Informations privilégiées / Autres communiqués GenSight Biologics obtient une autorisation d'accès compassionnel en France pour GS010/LUMEVOQ dans le traitement de la NOHL liée à la mutation ND4 Thérapie Génique GenSight Biologics NOHL GS010/LUMEVOQ Autorisation D'accès Compassionnel
BRIEF published on 11/13/2025 at 18:02, 7 months 9 days ago Franchissement de seuils par Heights Capital Management Obligations Convertibles Franchissement De Seuils GenSight Biologics Actions Et Droits De Vote Heights Capital
BRIEF published on 11/13/2025 at 18:02, 7 months 9 days ago Heights Capital Management crosses thresholds Convertible Bonds Crossing Thresholds Shares And Voting Rights GenSight Biologics Heights Capital
Published on 06/23/2026 at 16:10, 1 hour 40 minutes ago Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity
Published on 06/23/2026 at 16:00, 1 hour 50 minutes ago Secure Blockchain Appoints Former Polygon Executive Steven Bryson-Haynes as CEO to Drive Enterprise AI Commercialization
Published on 06/23/2026 at 15:45, 2 hours 5 minutes ago Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
Published on 06/23/2026 at 15:30, 2 hours 20 minutes ago Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board
Published on 06/23/2026 at 15:30, 2 hours 20 minutes ago Galantas Gold Completes Transaction to Acquire Andacollo Gold
Published on 06/23/2026 at 17:45, 5 minutes ago Burkhalter Group announces successful completion of capital increase
Published on 06/23/2026 at 17:45, 5 minutes ago Le Groupe Burkhalter annonce le succès de son augmentation de capital
Published on 06/23/2026 at 17:40, 9 minutes ago EQS-Adhoc: init innovation in traffic systems SE: Resolves on a capital increase of up to c. 10 % against cash contributions from authorized capital, with the exclusion of pre-emption rights
Published on 06/23/2026 at 17:40, 10 minutes ago Springer Nature to divest its consumer media businesses
Published on 06/23/2026 at 17:35, 14 minutes ago Fourth China International Supply Chain Expo Opens in Beijing
Published on 06/23/2026 at 16:47, 1 hour 2 minutes ago Déclaration des transactions sur actions propres réalisées du 15/06/2026 au 19/06/2026
Published on 06/23/2026 at 16:47, 1 hour 3 minutes ago Statement of transactions in own shares from June 15, 2026 to June 19, 2026
Published on 06/23/2026 at 15:44, 2 hours 6 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 15 au 19 juin 2026
Published on 06/23/2026 at 15:44, 2 hours 6 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 3 hours 50 minutes ago Neoen remporte un contrat long terme pour une nouvelle batterie de 200 MW / 8 heures en Ontario
